Haleon stock slips as Deutsche Bank keeps a 320p target
Published on 09/23/2026 at 11:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Haleon stock closed at 342.8p on the London Stock Exchange on September 23, 2026, according to the latest reported market snapshot. Deutsche Bank kept a 320p price target on September 23, leaving the target 22.8p below the cited closing price.
Growth estimates are easing
Proactive Investors reported on September 23, 2026, that Deutsche Bank models organic sales growth of 2.9 percent for the quarter, down from 3.1 percent in the second quarter. The 0.2 percentage point reduction makes North America the key operating variable in the current assessment.
The same report puts North American organic growth at 2.5 percent. Haleon's broad portfolio includes Sensodyne and Panadol, but the figures show that brand scale does not remove regional growth pressure.
Price stays above target
The 342.8p closing price stands 22.8p, or 7.1 percent, above Deutsche Bank's 320p target. That gap is a concrete comparison between the market level cited on September 23, 2026, and the broker's unchanged valuation marker.
For investors, the central issue is therefore the direction of organic growth rather than a single daily quote. A move from 3.1 percent to 2.9 percent in the modeled quarterly rate and the 2.5 percent North American estimate put execution and regional demand at the center of the valuation debate.
Haleon stock holds the market marker
Haleon stock was quoted at 342.8p on the London Stock Exchange on September 23, 2026. The 320p target and the 2.9 percent modeled organic growth rate provide the two clearest dated reference points for the shares.
Haleon stock facts
- Company: Haleon plc
- ISIN: GB00BMX86B70
- Ticker: HLN
- Trading venue: London Stock Exchange
- Price as of September 23, 2026: 342.8p GBP
- Sector / Industry: Consumer Staples / Personal Products
- Index membership: FTSE 100
